Global Angiotensin II Receptor Blockers Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Angiotensin II Receptor Blockers Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Angiotensin II receptor blockers help relax your veins and arteries to lower your blood pressure and make it easier for your heart to pump blood.
Angiotensin II Receptor Blockers report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Angiotensin II Receptor Blockers market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Chronic Kidney Diseases and Heart Failure are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Angiotensin II Receptor Blockers industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Angiotensin II Receptor Blockers key manufacturers include Merck & Co., AstraZeneca, Novartis, Teva, Bayer, GlaxoSmithKline, Sun Pharmaceutical and Mylan, etc. Merck & Co., AstraZeneca, Novartis are top 3 players and held % sales share in total in 2022.
Angiotensin II Receptor Blockers can be divided into Azilsartan, Candesartan, Eprosartan and Irbesartan, etc. Azilsartan is the mainstream product in the market, accounting for % sales share globally in 2022.
Angiotensin II Receptor Blockers is widely used in various fields, such as Chronic Kidney Diseases, Heart Failure and Kidney Failure in Diabetes,, etc. Chronic Kidney Diseases provides greatest supports to the Angiotensin II Receptor Blockers industry development. In 2022, global % sales of Angiotensin II Receptor Blockers went into Chronic Kidney Diseases filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Angiotensin II Receptor Blockers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Merck & Co.
AstraZeneca
Novartis
Teva
Bayer
GlaxoSmithKline
Sun Pharmaceutical
Mylan
Segment by Type
Azilsartan
Candesartan
Eprosartan
Irbesartan
Losartan
Olmesartan
Telmisartan
Valsartan
Chronic Kidney Diseases
Heart Failure
Kidney Failure in Diabetes
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Angiotensin II Receptor Blockers market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Angiotensin II Receptor Blockers, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Angiotensin II Receptor Blockers industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Angiotensin II Receptor Blockers in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Angiotensin II Receptor Blockers introduction, etc. Angiotensin II Receptor Blockers Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Angiotensin II Receptor Blockers market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Angiotensin II Receptor Blockers report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Angiotensin II Receptor Blockers market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Chronic Kidney Diseases and Heart Failure are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Angiotensin II Receptor Blockers industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Angiotensin II Receptor Blockers key manufacturers include Merck & Co., AstraZeneca, Novartis, Teva, Bayer, GlaxoSmithKline, Sun Pharmaceutical and Mylan, etc. Merck & Co., AstraZeneca, Novartis are top 3 players and held % sales share in total in 2022.
Angiotensin II Receptor Blockers can be divided into Azilsartan, Candesartan, Eprosartan and Irbesartan, etc. Azilsartan is the mainstream product in the market, accounting for % sales share globally in 2022.
Angiotensin II Receptor Blockers is widely used in various fields, such as Chronic Kidney Diseases, Heart Failure and Kidney Failure in Diabetes,, etc. Chronic Kidney Diseases provides greatest supports to the Angiotensin II Receptor Blockers industry development. In 2022, global % sales of Angiotensin II Receptor Blockers went into Chronic Kidney Diseases filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Angiotensin II Receptor Blockers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Merck & Co.
AstraZeneca
Novartis
Teva
Bayer
GlaxoSmithKline
Sun Pharmaceutical
Mylan
Segment by Type
Azilsartan
Candesartan
Eprosartan
Irbesartan
Losartan
Olmesartan
Telmisartan
Valsartan
Segment by Application
Chronic Kidney Diseases
Heart Failure
Kidney Failure in Diabetes
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Angiotensin II Receptor Blockers market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Angiotensin II Receptor Blockers, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Angiotensin II Receptor Blockers industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Angiotensin II Receptor Blockers in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Angiotensin II Receptor Blockers introduction, etc. Angiotensin II Receptor Blockers Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Angiotensin II Receptor Blockers market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices